Brands and Products
Chemours uses the power of chemistry to create better, reliable solutions.
Advanced performance materials are reshaping what’s possible in medical device design.
Creating a better world through responsible chemistry.
Our 2030 Goals
Our progress toward achieving Chemours’ Corporate Responsibility Commitment goals.
The Next Normal
Chemistry will help society navigate a new and better time.
Showing 261-266 of 266 results
DuPont announced that, in connection with the separation of its Performance Chemicals segment through the planned spin-off of The Chemours Company (" Chemours ") on July 1, 2015 , Chemours common stock will today begin "when-issued" trading on the New York Stock Exchange under the ticker symbol "CC WI".
WILMINGTON, Del., June 17, 2015 – Today, DuPont announced that the U.S. Securities and Exchange Commission (“SEC”) has declared effective the Registration Statement on Form 10 of The Chemours Company (“Chemours”).
Sets Record and Distribution Dates for DuPont Common Stockholders WILMINGTON, Del., June 5, 2015 – Today, DuPont announced that its board of directors declared a pro rata dividend to DuPont common stockholders of record as of 5:00 p.m.
The Chemours Company ( Chemours ) (NYSE: CC), a global chemistry company with leading market positions in titanium technologies, fluoroproducts and chemical solutions, announced it will release first quarter financial results after market close on Monday, May 1, 2017 .
The Chemours Company rang the opening bell at the NYSE on June 29, 2015.